Supreme Court rejects appeals brought by RFK Jr-founded anti-vaccine group over Covid shots

Supreme Court rejects appeals brought by RFK Jr-founded anti-vaccine group over Covid shots


Independent Presidential candidate Robert F. Kennedy Jr. speaks during a campaign rally at Legends Event Center on December 20, 2023 in Phoenix, Arizona. 

Rebecca Noble | Getty Images

The Supreme Court on Monday turned away two Covid-related appeals brought by Children’s Health Defense, the anti-vaccine group founded by independent presidential candidate Robert F. Kennedy Jr.

The decision by the justices not to hear the cases leaves in place lower court rulings against the group.

One case challenged the Food and Drug Administration’s emergency authorization of Covid-19 vaccines in December 2020, while the other was brought against Rutgers University in New Jersey over its Covid-19 vaccine mandate.

In the FDA case, the group claimed in court papers that Covid vaccines were “ineffective and lacked proper vetting.” The New Orleans-based 5th U.S. Circuit Court of Appeals found that Kennedy’s group did not have legal standing to sue.

In the Rutgers dispute, the Philadelphia-based 3rd U.S. Circuit Court of Appeals concluded that the plaintiffs “have not stated any plausible claim for relief.”

Kennedy himself took leave from the group he founded in April 2023 to run for president. He failed to make inroads in the Democratic primaries and is now running as an independent.

On the campaign trail he has mostly downplayed his anti-vaccine, activity but in November he spoke at a Children’s Health Defense conference.

Kennedy is listed as a lawyer on the Rutgers filing at the Supreme Court despite his leave of absence from the group.

In a separate vaccine-related case, the court also turned away a challenge to Connecticut’s decision to repeal a religious exemption for school vaccinations.



Source

Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More
Making U.S. biotech more competitive with China’s could help rare disease patients, experts say
Health

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say

The growth of China’s biotechnology sector has been staggering. Beijing is pumping money into the industry, backing research efforts and helping launch a new wave of labs and incubators in the country. That’s a problem for the U.S. biotech industry and also affects rare disease patients who are waiting for a cure. Among the experts […]

Read More